MORSE

All the posts published.
MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic, which highlights key metrics from Q1 2024 compared to performance…
At MORSE Consulting, we're delighted to share insights from Sherry O'Quinn's recent participation at the Rare Disease Day 2024 Summit held by…
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic highlighting key metrics from Q4 2023 compared to performance over…
We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall...
Happy Holidays from MORSE Consulting! As we enter the festive season and the close of our seventh year of operations, we wish…
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic highlighting key metrics from Q3 2023 compared to performance over…
Toronto, ON – October 3, 2023 – MORSE Consulting is delighted to announce a formal collaboration with Ben Faienza, President and Principal…
September 14, 2023 - We are thrilled to announce a groundbreaking collaboration between MORSE Consulting and Medlior Health Outcomes Research, two leaders…
For a more in-depth look at market access trends and timelines comparing 2022 data to that of the past four years, order…
We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall...
For a more in-depth look at market access trends and timelines comparing 2021 data to that of the past four years, order…
Happy Holidays from MORSE Consulting! As we enter the festive season and close our sixth year of operations, we express our heartfelt…
MORSE has been providing monthly data analytics and expert insights through our pCPA updates since 2017. Starting in 2022, MORSE is now…
Toronto, September 7, 2022 – MORSE Consulting is delighted to announce the addition of 2 new team members, Jaclyn Beca and Sang…
MORSE has been providing monthly data analytics and expert insights through our pCPA updates since 2017. Starting in 2022, MORSE is now…
MORSE has been providing data analytics and expert insights through our pCPA updates on a monthly basis since 2017. Starting in 2022,…
Recently announced changes to CADTH’s Reimbursement Review submission requirements, effective October 2022 necessitates completion of the Sponsor Summary of Clinical Evidence template.…
MORSE Consulting is pleased to release our Fifth Annual pCPA Year in Review Infographic – 2021 Edition.  This resource is aimed at…
pan-Canadian Pharmaceutical Alliance (pCPA): December 2021 Trends and Insights   UPDATE & REQUEST FOR PARTICIPATION IN A SURVEY MORSE has been providing…
Wishing you Season’s Greetings from MORSE Consulting! As we enter the holiday season and close our fifth year of operations, we would…
pan-Canadian Pharmaceutical Alliance (pCPA): November 2021 Trends and Insights   November 2021 Highlights: 3 products completed CADTH review 15 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): October 2021 Trends and Insights   October 2021 Highlights: 3 products completed CADTH review 6 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): September 2021 Trends and Insights   September 2021 Highlights: 5 products completed CADTH review 7 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): August 2021 Trends and Insights   August 2021 Highlights: 8 products completed CADTH review 4 products initiated pCPA…
Toronto, September 7, 2021 – MORSE Consulting is pleased to announce the addition of Katherine Scott as a Consultant. The Canadian public…
pan-Canadian Pharmaceutical Alliance (pCPA): July 2021 Trends and Insights   July 2021 Highlights: 5 products completed CADTH review 5 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): June 2021 Trends and Insights   June 2021 Highlights: 8 products completed CADTH review 12 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): May 2021 Trends and Insights   May 2021 Highlights: 6 products completed CADTH review 3 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): April 2021 Trends and Insights   April 2021 Highlights: 5 products completed CADTH review 6 products initiated pCPA…
Toronto, May 4th, 2021 – MORSE Consulting is pleased to release their 2021 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT)…
pan-Canadian Pharmaceutical Alliance (pCPA): March 2021 Trends and Insights   March 2021 Highlights: 5 products completed CADTH review 3 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): February 2021 Trends and Insights   February 2021 Highlights: 5 products completed CADTH review 7 products initiated pCPA…
Introduction The Canadian Association for Healthcare Reimbursement (CAHR) held its virtual Western Day Conference on February 9th, 2021.  Members of the MORSE…
pan-Canadian Pharmaceutical Alliance (pCPA): January 2021 Trends and Insights   January 2021 Highlights: 4 products completed CADTH review 9 products initiated pCPA…
MORSE Consulting is pleased to release our Fourth Annual pCPA Year in Review Infographic – 2020 Edition.  This resource is aimed at…
pan-Canadian Pharmaceutical Alliance (pCPA): December 2020 Trends and Insights   December 2020 Highlights: 8 products completed CADTH review 2 products initiated pCPA…
  Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of our fourth year of MORSE’s operations,…
pan-Canadian Pharmaceutical Alliance (pCPA): November 2020 Trends and Insights   November 2020 Highlights: 4 products completed CADTH review 8 products initiated pCPA…
COVID-19, HTA, PMPRB, RWE, Market Access, Drug Reimbursement
Introduction   The Canadian Association for Healthcare Reimbursement (CAHR) held its first virtual Market Access 201 conference on November 24, 2020.  Members…
pan-Canadian Pharmaceutical Alliance (pCPA): October 2020 Trends and Insights   October 2020 Highlights: 5 products completed CADTH review 7 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): September 2020 Trends and Insights   September 2020 Highlights: 1 product completed CADTH review 0 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): August 2020 Trends and Insights   August 2020 Highlights: 2 products completed CADTH review 2 products initiated pCPA…
Toronto, September 9, 2020 – MORSE Consulting is pleased to announce that Sal Cimino has joined our team as Senior Consultant, Private…
pan-Canadian Pharmaceutical Alliance (pCPA): July 2020 Trends and Insights   July 2020 Highlights: 6 products completed CADTH review 6 products initiated pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): June 2020 Trends and Insights   June Highlights: 4 products completed CADTH review 7 products initiated pCPA negotiations…
Consultations on Enhanced and Aligned Review Processes and Program Updates.   CADTH released its Pharmaceutical Reviews Update — Issue 16 on June…
pan-Canadian Pharmaceutical Alliance (pCPA): May 2020 Trends and Insights   May Highlights: 8 products completed CADTH review 5 products initiated pCPA negotiations…
pan-Canadian Pharmaceutical Alliance (pCPA): April 2020 Trends and Insights   April Highlights: 6 products completed CADTH review 4 products initiated pCPA negotiations…
CADTH recently released their annual business plan for 2020-2021. In this, the last year of their three-year strategic plan, CADTH aims to…
CADTH released its Pharmaceutical Reviews Update — Issue 15 on April 29, 2020.  Please find below MORSE Consulting’s summary of this update.…
Toronto, April 27, 2020 – MORSE Consulting is pleased to release our April 2020 Update to the Canadian Reimbursement Trends and Timelines…
pan-Canadian Pharmaceutical Alliance (pCPA): March 2020 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has launched a new website (https://www.pcpacanada.ca) with…
pan-Canadian Pharmaceutical Alliance (pCPA): February 2020 Trends and Insights   Due to the COVID-19 outbreak, the pCPA is implementing measures to work…
Toronto, February 18, 2020 – MORSE Consulting is pleased to expand and strengthen our service offering with the addition of Anita Carrie…
pan-Canadian Pharmaceutical Alliance (pCPA): January 2020 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the January 31, 2020 status…
MORSE Consulting is pleased to release our Third Annual pCPA Year in Review infographic - 2019 Edition.  This resource is aimed at…
pan-Canadian Pharmaceutical Alliance (pCPA): December 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the December 31, 2019 status…
  Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of MORSE’s third year of operation, we…
pan-Canadian Pharmaceutical Alliance (pCPA): November 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the November 30, 2019 status…
Summary of CADTH Drug Portfolio Information Session   Date: Monday, November 25, 2019 Time: 1:30 pm to 4:00 pm On November 25,…
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
pan-Canadian Pharmaceutical Alliance (pCPA): October 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the October 31, 2019 status…
Development of a framework for the generation and use of Real-World Evidence for cancer drug funding.   The CanREValue Collaboration hosted a…
pan-Canadian Pharmaceutical Alliance (pCPA): September 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the September 30, 2019 status…
Toronto, September 18, 2019 – MORSE Consulting is pleased to launch the Canadian Reimbursement Trends and Timelines report – a  comprehensive, credible…
pan-Canadian Pharmaceutical Alliance (pCPA): August 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the August 31, 2019 status…
MORSE, Author at MORSE Consulting Inc.